Literature DB >> 26626494

Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication.

Nicky Helsen1, Yannick Debing2, Jan Paeshuyse2, Kai Dallmeier2, Ruben Boon3, Mar Coll4, Pau Sancho-Bru4, Christel Claes3, Johan Neyts2, Catherine M Verfaillie3.   

Abstract

BACKGROUND & AIMS: Yearly, approximately 20million people become infected with the hepatitis E virus (HEV) resulting in over 3million cases of acute hepatitis. Although HEV-mediated hepatitis is usually self-limiting, severe cases of fulminant hepatitis as well as chronic infections have been reported, resulting annually in an estimated 60,000 deaths. We studied whether pluripotent stem cell (PSC)-derived hepatocytes, mesodermal and/or neuroprogenitor cells support HEV replication.
METHODS: Human PSC were differentiated towards hepatocyte-like cells, mesodermal cells and neuroprogenitors and subsequently infected with HEV. Infection and replication of HEV was analyzed by qRT-PCR, RNA in situ hybridization, negative strand RT-PCR, production of infectious virions and transfection with a transient HEV reporter replicon.
RESULTS: PSC-derived hepatocytes supported the complete replication cycle of HEV, as demonstrated by the intracellular presence of positive and negative strand HEV RNA and the production of infectious virions. The replication of the virus in these cells was inhibited by the antiviral drugs ribavirin and interferon-α2b. In contrast to PSC-derived hepatocytes, PSC-derived mesodermal cells and neuroprogenitors only supported HEV replication upon transfection with a HEV subgenomic replicon.
CONCLUSION: We demonstrate that PSC can be used to study the hepatotropism of HEV infection. The complete replication cycle of HEV can be recapitulated in infected PSC-derived hepatocytes. By contrast other germ layer cells support intracellular replication but are not infectable with HEV. Thus the early steps in the viral cycle are the main determinant governing HEV tissue tropism. PSC-hepatocytes offer a physiological relevant tool to study the biology of HEV infection and replication and may aid in the design of therapeutic strategies.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell culture model; Hepatitis E virus; Hepatocytes; Pluripotent stem cells

Mesh:

Substances:

Year:  2015        PMID: 26626494     DOI: 10.1016/j.jhep.2015.11.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  26 in total

1.  Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.

Authors:  Xianfang Wu; Viet Loan Dao Thi; Peng Liu; Constantin N Takacs; Kuanhui Xiang; Linda Andrus; Jérôme Gouttenoire; Darius Moradpour; Charles M Rice
Journal:  Gastroenterology       Date:  2017-12-24       Impact factor: 22.682

2.  Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Yao Su; Xiaotian Hao; Yufeng Cao; Li Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

Review 3.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 4.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 5.  Innate Immunity to Enteric Hepatitis Viruses.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 6.  Innate immunity in stem cell-derived hepatocytes.

Authors:  Lena Fischer; David C Hay; Cliona O'Farrelly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 7.  Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of in vitro and in vivo Evidence.

Authors:  Temi Lampejo
Journal:  J Clin Exp Hepatol       Date:  2022-02-22

8.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Pluripotent Stem Cell-Derived Hepatocyte-like Cells: A Tool to Study Infectious Disease.

Authors:  Robert E Schwartz; Yaron Bram; Angela Frankel
Journal:  Curr Pathobiol Rep       Date:  2016-07-30

Review 10.  Hepatitis E Pathogenesis.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Sabine Chapuy-Regaud; Nassim Kamar; Jacques Izopet
Journal:  Viruses       Date:  2016-08-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.